Standex Intl SEC Filings

Form 144 notice for Standex International Corporation (SXI) reports a proposed sale of 2,992 common shares through Fidelity Brokerage Services with an aggregate market value of $606,101.92. The filing lists 12,068,262 common shares outstanding and indicates the approximate date of sale as 08/18/2025 on the NYSE. The shares to be sold were acquired through restricted stock vesting: 1,171 shares on 09/06/2022, 1,035 shares on 10/25/2021 and 786 shares on 09/06/2021, each received as compensation. The filer reports no securities sold in the past three months and includes the standard representation about absence of undisclosed material information.

David A. Dunbar, President/CEO/Chairman and director of Standex International (SXI), reported a sale of company stock under a pre-existing 10b5-1 trading plan. On 08/13/2025 he disposed of 16,000 shares at $200 per share. The Form 4 also corrects prior reporting: 50,962 shares were gifted to a trust for the benefit of the reporting person’s spouse on 09/12/2023 and the trust’s holdings were inadvertently omitted from subsequent reports. Following the reported sale, the filing shows the reporting person (as trustee) beneficially owned 115,576 shares (indirect). The sale was executed pursuant to trading plans dated November 22, 2024, and the Form 4 was signed on 08/14/2025.

Standex International director Charles H. Cannon Jr. filed an amended Form 4 clarifying insider trading reported for May 9, 2025. The amendment corrects an earlier filing that mistakenly showed a direct sale of 2,779 common shares; the amendment states that the sale was executed by a trust rather than by Mr. Cannon personally. The transaction price shown on the form is $154.67.

The filing indicates beneficial ownership following the reported transaction includes 13,751 shares held indirectly as Trustee of a trust and a separate direct position of 2,936 shares. The amendment was submitted to remedy the original Form 4 filed May 13, 2025, and the document is signed on August 14, 2025.

Wasatch Advisors LP reports beneficial ownership of 866,830 shares of Standex International (SXI), representing 7.2% of the outstanding common stock. Wasatch discloses sole dispositive power over all 866,830 shares and sole voting power over 625,398 shares, with no shared voting or dispositive power reported.

The filing includes a certification that the securities are held in the ordinary course of business and were not acquired to change or influence control. The report classifies Wasatch as an investment adviser, making this a public notice that a registered adviser holds a material, passive stake in the company.

Standex International Corporation's Form 144 notifies a proposed sale of 16,000 shares of common stock on the NYSE through UBS Financial Services with an approximate aggregate market value of $3,200,000, and an indicated sale date of 08/13/2025. The filing lists 12,068,262 shares outstanding, which places the proposed sale at roughly 0.13% of the outstanding common stock.

The securities were acquired by the selling person through vested restricted stock units: 4,206 shares on 08/23/2023, 6,794 shares on 09/06/2023, and 5,000 shares on 09/06/2022. The form reports Nothing to Report for sales in the past three months. Several identifying fields in the filing (for example, filer CIK and issuer name/address sections) are blank or not populated in the provided text.

Champlain Investment Partners, LLC reported beneficial ownership of 603,095 shares of Standex International common stock, equal to 5.0% of the class. The filing shows Champlain has sole dispositive power over all 603,095 shares and sole voting power over 388,520 shares, with no shared voting or dispositive authority. The filer identifies itself as an investment adviser.

The filing includes a certification that the securities were acquired and are held in the ordinary course of business and were not acquired to change or influence control. The statement is signed by the firm's Chief Compliance Officer.

Standex International Corp. director Robin J. Davenport reported two small acquisitions of Common Stock under the company's Dividend Reinvestment Plan during the fiscal year. The filings show purchases of 1.918 shares on 02/27/2025 and 2.389 shares on 05/22/2025, recorded as acquisitions rather than open-market trades.

After these reinvestments the reporting person's direct beneficial ownership is listed as 4,057.307 shares at the end of the issuer's fiscal year. The form explicitly states these additions were made pursuant to the company's Dividend Reinvestment Plan, and the holdings are reported as direct ownership.

Standex International Corp (SXI) reported an annual Form 5 showing small, routine purchases of common stock by an officer under the companys Employee Stock Purchase Plan. The filing lists the reporting person as Arets Max and identifies the relationship as Officer: VP, Chief Information Officer. Purchases occurred on 12/31/2024 (23 shares at $158.942), 02/27/2025 (0.64 shares at $136.50), 03/31/2025 (28 shares at $137.182) and 05/22/2025 (1.714 shares at $150.035). The explanation states these acquisitions were made pursuant to the Employee Stock Purchase Plan. The filing shows 1,317.354 shares beneficially owned at the end of the issuers fiscal year ended 06/30/2025. The form is signed and dated 08/12/2025.

Standex International (SXI) – Form 4 filing dated 08/07/2025

Chief Financial Officer, Vice President & Treasurer Ademir Sarcevic reported an open-market sale of 3,047 common shares on 08/06/2025. The weighted-average price was $191.7967 per share, with individual trade prices ranging from $191.690 to $191.915. Following the transaction, Sarcevic’s directly held position decreased to 11,323 shares.

• Transaction code: “S” (sale).
• No derivative securities were involved.
• Filing made as a single reporting person; Rule 10b5-1 box not checked.

The sale represents a liquidity event by a senior executive but does not on its face indicate any change to company fundamentals. Investors may weigh the timing—shortly after fiscal year-end—against the executive’s remaining equity stake.